Michail Ivov Dimitrov

Dr. Michail Ivov Dimitrov


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2026 in Bioengineering
Verified
Journal Article
Open access
PDF file
GRGeorgi Dimitrov Raykov
Georgi Dimitrov Raykov
JAJakob Adolf
Jakob Adolf
BHBenedikt Jasper Hochbein
Benedikt Jasper Hochbein
GEGeorgi Enev
Georgi Enev
DTDimitar Tenev
Dimitar Tenev
NDNikolay Dimitrov
Nikolay Dimitrov
Biodegradable magnesium (Mg)-based implants represent a paradigm shift in orthopedic biomaterials, offering temporary mechanical support, inherent osteogenic bioactivity, and elimination of hardware removal surgery. These properties are particularly attractive for sports orthopedic applications, including anterior cruciate ligament (ACL) reconstruction, rotator cuff repair, meniscal fixation, and osteochondral fragment refixation, where young, active patients demand rapid return to function and where permanent metallic hardware poses long-term risks of stress shielding, imaging artifact, and reoperation. Despite extensive preclinical evidence demonstrating that Mg-based interference screws promote fibrocartilaginous enthesis regeneration, attenuate peri-tunnel bone loss, and achieve biomechanical fixation comparable to titanium, no human clinical trial has yet evaluated Mg fixation devices for soft-tissue reconstruction in sports medicine. Meanwhile, clinical fracture fixation data from over 468 patients across multiple trials and a meta-analysis confirm complication rates equivalent to those of titanium. This narrative review synthesizes the current evidence on Mg alloy design, surface engineering strategies, preclinical sports medicine applications, clinical translation in fracture fixation, imaging compatibility, and the remaining barriers to clinical adoption in sports orthopedic surgery. By mapping the translational gap between promising animal data and the absence of clinical sports medicine trials, this review aims to guide future research priorities and accelerate the pathway toward clinical application of Mg-based devices in sports orthopedics.

10 October 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
VAVladislav Andonov
Vladislav Andonov
VVVensan Velchov
Vensan Velchov
YNYasen IVo Nikolov
Yasen IVo Nikolov
NCNikolay Cherkezov
Nikolay Cherkezov
DTDimitar Tenev
Dimitar Tenev
NDNikolay Dimitrov
Nikolay Dimitrov
Background: Total hip arthroplasty (THA) and the diagnosis of periprosthetic joint infection (PJI) have each acquired a technology that measures with high precision: intraoperative navigation, which reports component position to within a few degrees, and molecular methods, which identify the infecting organism and the host response at genomic resolution. Objective: To establish whether the measured accuracy has been shown to reach the patient as a clinical outcome. Methods: This is a narrative review, reported according to SANRA. MEDLINE, Scopus, and Web of Science databases were searched from inception to 31 August 2026. English-language studies in humans were eligible if they reported positional or diagnostic accuracy, a patient-level clinical or economic outcome after THA or after treatment of PJI or osteomyelitis, or a factor modifying the relation between the two. Animal, in vitro, and cadaveric studies, conference abstracts, and reports without extractable data were excluded. Forty studies were included. No pooled estimate was calculated, and no new statistical analysis was performed. Results: Navigation reduced positional outliers consistently, but in two matched claims-based cohorts of patients with morbid obesity (4499 and 5835 patients), it was not associated with lower rates of PJI, dislocation, periprosthetic fracture, mechanical loosening, or revision within two years. Candidate immunogenetic variants in osteomyelitis have never been tested against a treatment decision. Metagenomic sequencing was no more accurate than culture (sensitivity 63.2% versus 68.4%; specificity 80.0% versus 95.0%) except after antibiotic exposure. Reported infection rates and test accuracy both change with the case definition applied. Conclusions: In both settings, the limiting factor is the design of the studies linking measurement to outcome rather than the precision of the measurement.